Cantor Fitzgerald Reiterates Overweight on Enovix, Maintains $25 Price Target

Benzinga · 1d ago
Cantor Fitzgerald analyst Derek Soderberg reiterates Enovix (NASDAQ:ENVX) with a Overweight and maintains $25 price target.